Back to companies
Earlybird Portfolio
Rivia
Rivia is a Zurich-based technology company building a data engine that powers the future of clinical trial intelligence. Rivia was founded on the belief that new drugs can be brought to market more successfully with a fraction of today’s capital. Over the past two years, European and US based biotechs running global clinical trials on Rivia have demonstrated measurable impact, from earlier understanding of therapeutic potential to significantly more efficient trial execution. In the years ahead, the company will scale its platform and embedded intelligence to help bring groundbreaking therapies to market faster.
Founded: 2022 Invested: 2025
Founders
Erik Scalfaro Tiago Kieliger
HQ
Zurich
Earlybird Lead

SIMILAR COMPANIES
WE INVEST BECAUSE
WE BELIEVE
Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.














